Calibrate Review (2026): Proceed with Caution
Last updated: March 2026 Disclosure: This page contains affiliate links. We may earn a commission if you enroll through a link. All recommendations are independently made. Compounded medications are not FDA-approved and are regulated differently from brand-name drugs. Instant Dec
Last updated: March 2026
Disclosure: This page contains affiliate links. We may earn a commission if you enroll through a link. All recommendations are independently made. Compounded medications are not FDA-approved and are regulated differently from brand-name drugs.
The FDA has proposed excluding semaglutide and liraglutide from the 503B bulk compounding list, with public comments open through June 29, 2026. If finalized, this could affect the availability, pricing, and continuity of some compounded GLP-1 programs. We will update this page as the regulatory situation develops.
Instant Decision Summary
- Status: Proceed with caution — verify availability before enrolling
- Best alternatives: Henry Meds or Mochi
Where Calibrate Stands Out
Calibrate was one of the first programs to combine GLP-1 medication with structured metabolic coaching. The integrated approach — medication plus curriculum — was its core differentiator.
Where Calibrate Falls Short
Calibrate has adjusted its offering in recent periods. Availability and program structure should be confirmed directly before enrolling. Do not assume current availability or pricing matches what was offered previously.
Who This Is For
- Users specifically seeking a structured metabolic program with GLP-1
- Users who have verified current program availability in their state
Who Should Avoid Calibrate
- Users who need immediate access — verify availability first
- Users who want a simpler, faster enrollment process
Also Consider
- Visit Henry Meds → — Simple, bundled, Typically $297–$397/mo for GLP-1 medications
- Visit Mochi → — Best ongoing support
- Visit Calibrate →